Search Results

Keywords: synthetic

California’s new organic certification plan could help cannabis growers’ bottom line

June 26, 2020

A plan to roll out a novel organic marijuana certification in California could generate more business opportunities for brands looking to differentiate themselves by charging health-conscious consumers a premium for their products. With cannabis illegal under federal law, marijuana businesses cannot call products organic under the U.S. Department of Agriculture’s certification program. So California has […]

Read More

Competition grows in Germany’s medical cannabis extracts market

June 5, 2020

Canadian cannabis producer Tilray announced the availability of a new full-spectrum extract for Germany’s medical market, the company’s first product in that market offering a larger CBD concentration than THC. The product has 5 milligrams of THC per millilitre and 20 milligrams of CBD per millilitre. Tilray’s announcement didn’t disclose the size of the bottle. […]

Read More

England’s medical cannabis market shows little growth as of early 2020

May 14, 2020

England’s medical cannabis market has barely gotten off the ground since launching about 19 months ago, with a two-tier system in which few patients access products through legal channels while most resort to illicit suppliers. Looking ahead, however, some industry insiders are hopeful that recently implemented import rules could boost the number of legal medical cannabis prescriptions […]

Read More

Brazil approves first medical cannabis product under 2019 regulations

April 23, 2020

Brazil’s health authorities authorized the first medical cannabis product registered under rules created in December 2019, marking an important milestone for the industry in Latin America’s largest economy. The THC-free CBD product, registered to Brazilian pharmaceutical giant Prati-Donaduzzi, obtained “sanitary authorization” this week, according to a notice in the country’s official Gazette. The company declined interview requests […]

Read More

Research Project

April 1, 2020 · Updated June 6, 2021

The U.S. Food and Drug Administration is approving a growing number of applications from cannabis companies looking to conduct clinical trials studying medical marijuana. That development could lead to multiple cannabis-based medicines—including flower—receiving FDA approval to be commercialized and sold within the next five years. While attitudes might be changing at the FDA, obtaining agency […]

Read More

Week in Review: UN drug chief ponders validity of cannabis control treaties, coronavirus effects on marijuana sector, US authorities loosen hemp testing rules & more

February 29, 2020 · Updated June 5, 2020

The United Nations narcotics enforcement agency president considers whether drug control treaties are outdated, experts share insights on how the coronavirus might affect the marijuana industry, MJ labs could see new opportunities in testing hemp – and more of the week’s top cannabis business news. UN drug chief questions drug control conventions The head of the […]

Read More

In major shift, UN drug chief questions whether control treaties involving cannabis are out of date

February 27, 2020 · Updated February 28, 2020

The president of the narcotics enforcement agency of the United Nations is questioning whether the agency’s decades-old drug conventions are outdated given global policy developments in recent years involving drugs such as cannabis. During a presentation Thursday for the International Narcotics Control Board’s (INCB) 2019 annual report, President Cornelis P. de Joncheere discussed the developments taking place with regard […]

Read More

Stem Holdings executive outlines how federal regulations will impact the hemp industry

February 1, 2020 · Updated June 6, 2021

Vertically integrated cannabis producer Stem Holdings is dedicated to organic production and high-quality standards—attributes the company plans to apply to its new ventures in the hemp industry. Ellen Deutsch, Stem Holdings’ executive vice president and chief operating officer, told Marijuana Business Magazine that hemp and CBD companies must focus on developing brands that are sustainably […]

Read More

German pharmacies have new pharmaceutical CBD supplier

January 22, 2020

The medical cannabidiol market is becoming more competitive in Germany, as 2020 kicks off with one new CBD option that pharmacists can dispense to patients. A Cologne, Germany-based distributor of medical cannabis started offering pure CBD in kits with which pharmacists can compound preparations according to a doctor’s prescription. The kits allow pharmacists to prepare […]

Read More

GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug

January 13, 2020

A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019. The company’s fourth-quarter sales beat consensus analyst expectations of $102.4 million. GW attributed the sales figures to physicians […]

Read More

The future of the medical marijuana industry: Q&A with Andrea Small-Howard, chief science officer at GB Sciences

December 12, 2019 · Updated October 8, 2021

Andrea Small-Howard has a unique view into how the medical side of the cannabis space is evolving. She’s the chief science officer at GB Sciences, a Las Vegas-based marijuana company pursuing two strategies – one recreational, and the other aiming for U.S. Food and Drug Administration (FDA) approval of its medical cannabis products. Small-Howard has […]

Read More